We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AnteoTech

We’re an Australian public company headquartered in Brisbane. Our patented metal-ion-based technology is applied to improve the performance of next-generation lithium-ion batteries and in the development of diagnostic solutions in Life Sciences.

Latest Content

Illustration of antibodies binding targets, highlighting next-generation bioconjugation chemistry.

Next-Generation Bioconjugation Chemistry Delivers Better Sensitivity at Lower Cost

This comparative study presents head-to-head performance data from CLIA experiments using Tosyl-activated particles versus a next-generation noncovalent surface activation approach, across four clinically relevant antibodies.

3D molecular structures illustrating bioconjugation strategies, highlighting chemical linkages for advanced bioconjugation research.

Rethink Bioconjugation To Cut Costs and Improve Assay Performance

This whitepaper introduces a metal ion complex-based surface activation technology that addresses these challenges head-on, offering a smarter path to faster, more reproducible, and more cost-efficient bioconjugation.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter